BRPI0907298A2 - preparação solúvel em água, método para produzir uma preparação e uso de uma preparação - Google Patents

preparação solúvel em água, método para produzir uma preparação e uso de uma preparação

Info

Publication number
BRPI0907298A2
BRPI0907298A2 BRPI0907298A BRPI0907298A BRPI0907298A2 BR PI0907298 A2 BRPI0907298 A2 BR PI0907298A2 BR PI0907298 A BRPI0907298 A BR PI0907298A BR PI0907298 A BRPI0907298 A BR PI0907298A BR PI0907298 A2 BRPI0907298 A2 BR PI0907298A2
Authority
BR
Brazil
Prior art keywords
preparation
producing
water soluble
soluble preparation
water
Prior art date
Application number
BRPI0907298A
Other languages
English (en)
Inventor
Holger Piotrowski
Markus Müller
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of BRPI0907298A2 publication Critical patent/BRPI0907298A2/pt
Publication of BRPI0907298B1 publication Critical patent/BRPI0907298B1/pt
Publication of BRPI0907298B8 publication Critical patent/BRPI0907298B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0907298A 2008-05-13 2009-04-30 preparação solúvel em água, sólida e no formato de película compreendendo álcool de polivinila e substância oleosa, e método para produzí-la BRPI0907298B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008023345.5A DE102008023345B4 (de) 2008-05-13 2008-05-13 Filmförmige Zubereitung mit öligen Substanzen zur oralen Verabreichung
DE102008023345.5 2008-05-13
PCT/EP2009/003138 WO2009138170A2 (de) 2008-05-13 2009-04-30 Filmförmige zubereitung mit öligen substanzen zur oralen verabreichung

Publications (3)

Publication Number Publication Date
BRPI0907298A2 true BRPI0907298A2 (pt) 2016-07-05
BRPI0907298B1 BRPI0907298B1 (pt) 2019-05-28
BRPI0907298B8 BRPI0907298B8 (pt) 2021-05-25

Family

ID=40863404

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907298A BRPI0907298B8 (pt) 2008-05-13 2009-04-30 preparação solúvel em água, sólida e no formato de película compreendendo álcool de polivinila e substância oleosa, e método para produzí-la

Country Status (13)

Country Link
US (1) US8758803B2 (pt)
EP (1) EP2273987B1 (pt)
JP (1) JP5654451B2 (pt)
KR (1) KR101588479B1 (pt)
CN (1) CN102026630B (pt)
AU (1) AU2009248328C1 (pt)
BR (1) BRPI0907298B8 (pt)
CA (1) CA2724191C (pt)
DE (1) DE102008023345B4 (pt)
ES (1) ES2426963T3 (pt)
MX (1) MX2010011923A (pt)
WO (1) WO2009138170A2 (pt)
ZA (1) ZA201007107B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9532952B2 (en) 2011-01-28 2017-01-03 Physician's Seal, LLC Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en) 2011-01-28 2012-08-02 Zx Pharma, Llc Controlled-release melatonin composition and related methods
TR201808978T4 (tr) 2011-02-11 2018-07-23 Zx Pharma Llc Çok partiküllü l-mentol formülasyonları ve ilgili yöntemler.
US8808736B2 (en) 2011-02-11 2014-08-19 Zx Pharma, Llc Enteric coated multiparticulate controlled release peppermint oil composition and related methods
US8911780B2 (en) 2011-02-11 2014-12-16 Zx Pharma, Llc Multiparticulate L-menthol formulations and related methods
DE202011004425U1 (de) * 2011-03-25 2012-03-27 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung zur Anwendung bei Verdauungsbeschwerden
EP2988824B1 (en) 2013-04-23 2018-11-07 Zx Pharma, Llc Enteric coated multiparticulate composition with proteinaceous subcoat
DK3174530T3 (en) 2014-07-30 2018-11-26 Merck Patent Gmbh DIRECT COMPATIBLE POLYVINYL ALCOHOLS
KR20170036768A (ko) * 2014-07-30 2017-04-03 메르크 파텐트 게엠베하 미세결정성 셀룰로오스를 포함하는 직접 압축성 조성물
US12544446B2 (en) 2018-03-02 2026-02-10 Vitiprints, LLC Printed delivery device having supplements
WO2020136606A1 (en) 2018-12-29 2020-07-02 3M Innovative Properties Company Oral articles and methods of use
WO2020136620A1 (en) 2018-12-29 2020-07-02 3M Innovative Properties Company Oral articles and methods of use
IL292534A (en) 2019-11-04 2022-06-01 Maabarot Products Ltd Orally administrable films comprising poorly water soluble active ingredients and preparation thereof
DE102020112422A1 (de) * 2020-05-07 2021-11-11 Lts Lohmann Therapie-Systeme Ag Verfahren zur Herstellung eines oralen Dünnfilms umfassend Mikropartikel
CN111939332B (zh) * 2020-08-25 2022-07-05 深圳市泓云润泽医疗科技有限公司 一种在消化道中可溶解的医用材料及其应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001A (en) * 1847-03-06 Horse-power
GB1142325A (en) 1965-05-14 1969-02-05 Higham Stanley Russell Means for administering drugs
DE2449865B2 (de) 1974-10-17 1981-06-19 Schering Ag Berlin Und Bergkamen, 1000 Berlin Folienförmiges Arzneimittel
AU514195B2 (en) 1975-12-15 1981-01-29 F. Hoffmann-La Roche & Co. Dosage form
EP0219762B1 (de) 1985-10-09 1990-12-27 Desitin Arzneimittel GmbH Verfahren zur Herstellung einer Darreichungs- und Dosierungsform für Arzneimittel-Wirkstoffe, Reagentien oder andere Wirkstoffe
WO1991005540A1 (de) 1989-10-14 1991-05-02 Desitin Arzneimittel Gmbh Mund- und zahnpflegemittel
DE4018247A1 (de) 1990-06-07 1991-12-12 Lohmann Therapie Syst Lts Herstellungsverfahren fuer schnellzerfallende folienfoermige darreichungsformen
US5192802A (en) * 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
DE19652257A1 (de) * 1996-12-16 1998-06-18 Lohmann Therapie Syst Lts Einzeln dosierte, bei Kontakt mit Flüssigkeit schnell zerfallende, wirkstoff- und insbesondere aromastoffhaltige, folienförmige Darreichnungsform
US7083781B2 (en) * 1999-08-19 2006-08-01 Lavipharm S.A. Film forming polymers, methods of use, and devices and applications thereof
US20050019291A1 (en) 2003-07-24 2005-01-27 Yelena Zolotarsky Emulsion composition of polyvinyl alcohol which forms a peelable film on skin
EP1845979A4 (en) 2005-01-19 2009-11-11 Neurohealing Pharmaceuticals I METHOD AND COMPOSITIONS FOR REDUCING STORAGE PRODUCTION
DE102006003512A1 (de) * 2006-01-24 2007-08-02 Bayer Schering Pharma Ag Plättchenförmige Arzneimittel zur transbukkalen Applikation von Arzneistoffen
WO2008089151A2 (en) * 2007-01-12 2008-07-24 Monosol Rx, Llc High dose film compositions and methods of preparation

Also Published As

Publication number Publication date
MX2010011923A (es) 2010-11-30
DE102008023345B4 (de) 2014-12-04
EP2273987B1 (de) 2013-07-31
ZA201007107B (en) 2011-05-25
AU2009248328B2 (en) 2014-10-23
CN102026630B (zh) 2015-11-25
JP5654451B2 (ja) 2015-01-14
US8758803B2 (en) 2014-06-24
WO2009138170A3 (de) 2010-03-18
WO2009138170A2 (de) 2009-11-19
KR101588479B1 (ko) 2016-01-25
CA2724191A1 (en) 2009-11-19
CN102026630A (zh) 2011-04-20
AU2009248328C1 (en) 2015-05-07
US20110064830A1 (en) 2011-03-17
ES2426963T3 (es) 2013-10-28
EP2273987A2 (de) 2011-01-19
CA2724191C (en) 2016-05-24
BRPI0907298B8 (pt) 2021-05-25
AU2009248328A1 (en) 2009-11-19
BRPI0907298B1 (pt) 2019-05-28
JP2011520818A (ja) 2011-07-21
AU2009248328B9 (en) 2014-11-20
DE102008023345A1 (de) 2009-11-19
KR20110009700A (ko) 2011-01-28

Similar Documents

Publication Publication Date Title
BRPI1010775A2 (pt) composição, método para preparar uma composição, e, uso de uma composição.
BR112012010286A2 (pt) painel transparente, método para produção de um painel transparente, e, uso de um painel transparente
BRPI0923748A2 (pt) Método para a preparação de dióis
BRPI0918234A2 (pt) fundacao de unidade offshore, unidade offshore, metodo para construcao de unidade offshore
BRPI0918359A2 (pt) composto, composição agroquímica, uso da composição agroquímica e método para preparação do composto
ES2405774T8 (es) Métodos para preparar andamio poroso para la ingeniería de tejidos
FI20085171L (fi) Uudet selluloosajohdannaiset, menetelmä niiden valmistamiseksi sekä niiden käyttö
BRPI1006633A2 (pt) bolo liofilizado, metodo para a fabricação de um bolo liofilizado e uso de bolo liofilizado
BRPI0912384A2 (pt) composição, e, método para preparar uma composição
BRPI0912403A2 (pt) pasta aquosa, concreto, e, métodos para preparar uma pasta aquosa e para preparar um concreto
BRPI0908092A2 (pt) Edulcorante, método para preparar uma composição edulcorante, e, composição edulcorante
BRPI0812232A2 (pt) Método para produção de polissacarídeo solúvel em água
BRPI1010937A2 (pt) composto, uso de um composto, e, método para tratar câncer
BRPI0911024A2 (pt) "método para produzir macarrão instantâneo"
ES2858225T8 (es) Procedimiento para producir elementos estructurales templados
BR112012000623A2 (pt) composição de emulsão estabilizada, método, e, método para preparar uma composição de emulsão estabilizada
BRPI0814299A2 (pt) Preparação sólida, e, métodos para estabilizar um composto em uma preparação sólida, e para produzir uma preparação sólida
BR112012019936A2 (pt) uso de um composto, método de preparação de um composto, método e composto
BRPI0813192A2 (pt) composto para a regeneração de tecidos e método de preparação de um composto para a regeneração de tecidos
UY33094A (es) Procedimiento para la preparacion de dronedarona
FI20075399L (fi) Uudet dispersiot ja menetelmä niiden valmistamiseksi
BRPI1006996A2 (pt) composição, método e uso
BR112012004173A2 (pt) "composto, composição, método para preparar uma composição, e, uso de um composto"
BR112012010298A2 (pt) painel, método para produzir um painel, e, uso em um painel
BRPI1007624A2 (pt) composto, método para preparar uma composição, composto ou sal farmaceuticamente aceitável deste e uso de um composto ou um sal farmaceuticamente aceitável deste

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/05/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 28/05/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 30/04/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 13A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2668 DE 22-02-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.